Haruhiko Imamoto

Phase III Trial Comparing Intraperitoneal and Intravenous Paclitaxel Plus S-1 Versus Cisplatin Plus S-1 in Patients With Gastric Cancer With Peritoneal Metastasis: PHOENIX-GC Trial

Hironori Ishigami, Yoshiyuki Fujiwara, Ryoji Fukushima et al. · Journal of Clinical Oncology · 2018 · 356 citations

Medicine, Oncology, Pharmacology +13

Endoscopic screening of early esophageal cancer with the Lugol dye method in patients with head and neck cancers

Hitoshi Shiozaki, Hideaki Tahara, Kenji Kobayashi et al. · Cancer · 1990 · 221 citations · Full text

Medicine, Oncology, Cancer Screening +12

Randomized phase III study comparing the efficacy and safety of irinotecan plus S-1 with S-1 alone as first-line treatment for advanced gastric cancer (study GC0301/TOP-002)

Hiroyuki Narahara, Hiroyasu Iishi, Hiroshi Imamura et al. · Gastric Cancer · 2011 · 160 citations · Full text

Medicine, Oncology, Pharmacotherapy +10

A phase II study of paclitaxel by weekly 1-h infusion for advanced or recurrent esophageal cancer in patients who had previously received platinum-based chemotherapy

Ken Kato, Makoto Tahara, Shuichi Hironaka et al. · Cancer Chemotherapy and Pharmacology · 2010 · 115 citations

Medicine, Oncology, Pharmacology +10

Phase II study of intraperitoneal paclitaxel plus S-1/oxaliplatin for gastric cancer with peritoneal metastasis: SOX+IP PTX trial.

Yoshiyuki Fujiwara, Hironori Ishigami, Hiroto Miwa et al. · Journal of Clinical Oncology · 2016 · 98 citations

Medicine, Oncology, Pharmacology +17